At Astellas, a commitment to creating a brighter future is the foundation of everything we do.
Astellas Pharma Inc. is a global pharmaceutical company with a simple vision – to produce exceptional medicines that change tomorrow for patients in need. Headquartered in Tokyo, Astellas was founded in 2005 through the merger of Yamanouchi and Fujisawa, bringing together nearly two centuries of collective experience in producing pharmaceutical drugs. We combine the deep expertise brought by this long heritage with the forward-thinking outlook of a young company. At the heart of that outlook is the patient.
Now, Astellas employs more than 17,500 people globally and is a world leader in the development of innovative new medicines. With our ethos of CHANGING TOMORROWTM, Astellas is committed to exploring therapeutic areas in which there is a vital need for treatments that improve and lengthen patients’ lives. We’re not in the business of making ‘me too’ medicines. We strive to develop therapies that are first-in-class and best-in-class. Treatments that offer patients and their doctors genuinely new options for improving care.
